January 26, 2026
Do you know the city home to the pharmaceutical company Sanofi? Answer in today's STAT crossword.
María Teresa Pérez Zaballos founded Endogene.Bio after she spent five years seeking a diagnosis for her pain.
Sophie Park for STAT

STAT+ | Endometriosis often takes years to diagnose. Startups want to change that

Diagnosing endometriosis still often requires a surgical procedure. Researchers, startups are testing blood and genetic markers to change that

By Theresa Gaffney


Alex Pretti remembered by health care workers at a Minneapolis vigil as a ‘stand-up guy’

At Minneapolis vigil for Alex Pretti, ICU nurse shot by federal agents, health workers describe grief and a public health crisis

By Megan Molteni


CDC pauses, then unpauses billions in public health infrastructure grants to states

HHS says it paused public health infrastructure grants to ‘ensure alignment with administration and agency priorities.'

By Chelsea Cirruzzo



President Barack Obama presents the Presidential Medal of Freedom to former CDC Director William Foege during a ceremony on May 29, 2012. Foege has died at the age of 89.
https://www.gettyimages.com/detail/news-photo/president-barack-obama-presents-the-presidential-medal-of-news-photo/145423325?adppopup=true

Public health giant William Foege, who helped eradicate smallpox, has died at 89

Foege, a sharp critic of RFK Jr., helped eradicate smallpox, led the CDC, and mentored generations of public health leaders.

By Helen Branswell


Opinion: Our podcast ‘Why Should I Trust You?’ connects MAHA and public health. Here’s what we’ve learned

Podcasters dedicated to rebuilding trust in public health and science say engaging with MAHA adherents has taught them the power of shared pain.

By Tom W. Johnson and Brinda Adhikari


Opinion: Shared decision-making on vaccines is not the enemy

Most vaccine proponents are making two strategic risk communication mistakes on shared-decision making, an expert writes.

By Peter M. Sandman


Bioethicist Holly Fernandez Lynch, seen here at a STAT event last year, was an author on a paper raising questions about a new FDA policy.
Brooke Alexander for STAT

STAT+ | FDA’s new ‘plausible mechanism pathway’ for personalized gene editing raises concerns

A new FDA pathway meant to enable one-time gene-editing cures is welcomed in theory but could, ethicists warn, become a Pandora's box.

By Jason Mast


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.